CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal, as co-author of the recent Cerevel Therapeutics study titled, Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial, published in The Lancet.
News at CenExel
RSV: Perspectives and Insight from a Healthcare Hero
As a former healthcare worker at Primary Children’s Hospital in Salt Lake City, UT, I begin to get more and more concerned about cold and flu season as it pertains to babies, as passing on a simple adult cold to an infant could be dangerous, even life-threatening....
Pediatric Meningitis: Learn to Identify the Symptoms
Pediatric meningitis is a serious condition that can put your child or teen’s health at risk. Because meningitis is easily spread among individuals in close quarters, children who attend Salt Lake City schools or daycares are at an increased risk of contracting the...
Pediatric Flu: 6 Treatment Tips for Parents
Caring for a sick child can be incredibly stressful for a parent. This is especially true when a child is infected with the pediatric flu. Thousands of children in Salt Lake City experience the pediatric flu each year; however, many of these cases can be prevented...
Pediatric Flu Part Two: Flu Vaccines for Children
Pediatric Influenza Vaccinations Influenza infections can be very dangerous for young children. Severe, even life-threatening, complications are most common for children under the age of two. Children five and under often need medical treatment if they contract the...
Pediatric Flu Part One: Does My Child Have the Flu or a Cold?
Children and the Flu There are a lot of misconceptions about the term “flu.” People often refer to a stomach bug as “the flu,” however, influenza is a respiratory illness caused by a virus. Parents might find it challenging to determine whether their son or daughter...